Table 5 Clinical efficacy change score by multivariate regression analyses parameter estimates
Data | Treatment | Mean ± SD | 95% Conf.Interval | p-value | |
|---|---|---|---|---|---|
lower | upper | ||||
TNSS score | Loratadine | −0.574 (0.709) | −0.416 | −0.732 | 0. 343 |
Ginger extract | −0.666 (0.649) | − 0.522 | − 0.811 | ||
Minimal cross section area of right nose (cm2) | Loratadine | 0.004 (0.032) | −0.003 | 0.011 | 0.551 |
Ginger extract | 0.007 (0.037) | −0.001 | 0.016 | ||
Minimal cross section area of left nose (cm2) | Loratadine | −0.001 (0.033) | −0.008 | 0.006 | 0.2357 |
Ginger extract | 0.005 (0.033) | −0.002 | 0.012 | ||
Volume estimates of the right nasal cavity (cm3) | Loratadine | 0.011 (0.285) | −0.052 | 0.075 | 0.106 |
Ginger extract | 0.086 (0.326) | 0.014 | 0.159 | ||
Volume estimates of the left nasal cavity (cm3) | Loratadine | −0.006 (0.265) | −0.065 | 0.053 | 0.02* |
Ginger extract | 0.094 (0.288) | 0.030 | 0.158 | ||
Distance from the nostril of right nose (cm) | Loratadine | −0.003 (0. 076) | −0.020 | 0.014 | 0.402 |
Ginger extract | 0.006 (0. 066) | −0.008 | 0.021 | ||
Distance from the nostril of left nose (cm) | Loratadine | 0.010 (0. 079) | −0.008 | 0.027 | 0.008* |
Ginger extract | −0.023 (0. 097) | −0.045 | − 0.002 | ||
Total RQLQ score | Loratadine | −0.266 (0.299) | −0.199 | − 0.332 | 0.701 |
Ginger extract | −0.283 (0.276) | −0.222 | − 0.345 | ||